Sequence variability among-different parvovirus B19 isolates

被引:93
作者
Hemauer, A
vonPoblotzki, A
Gigler, A
Cassinotti, P
Siegl, G
Wolf, H
Modrow, S
机构
[1] UNIV REGENSBURG, INST MED MIKROBIOL & HYG, D-93053 REGENSBURG, GERMANY
[2] INST KLIN MIKROBIOL & IMMUNOL, CH-9001 ST GALLEN, SWITZERLAND
关键词
D O I
10.1099/0022-1317-77-8-1781
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Parvovirus B19 is the causative agent of a variety of clinical manifestations, ranging from asymptomatic to severe infection, The basis for this complex pattern of B19-associated diseases is as yet poorly understood. In general there are two different possibilities: firstly, the infected individuals may have a genetic or acquired predisposition, which renders them susceptible for a certain course of infection; secondly, differences in the B19 genome may result in different outcomes of infection, In order to investigate this second possibility we have partially sequenced the genomes of 20 different B19 isolates derived from serum samples from patients with various B19-associated diseases. Four distinct regions, which cover nearly half of the genome and include parts of the coding regions of all three major B19 proteins - NS1, VP1 and VP2, were selected for sequencing. Comparisons between the different extracted virus isolates at the DNA and protein levels revealed that isolates from patients with persistent parvovirus B19 infection show a tendency towards higher genome variability with respect to isolates derived from persons with acute infection.
引用
收藏
页码:1781 / 1785
页数:5
相关论文
共 21 条
  • [1] ANDERSON MJ, 1988, LANCET, V1, P535
  • [2] MOLECULAR, CELLULAR AND CLINICAL ASPECTS OF PARVOVIRUS B19 INFECTION
    BROWN, KE
    YOUNG, NS
    LIU, JM
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1994, 16 (01) : 1 - 31
  • [3] PERSISTENT HUMAN PARVOVIRUS B19 INFECTION FOLLOWING AN ACUTE INFECTION WITH MENINGITIS IN AN IMMUNOCOMPETENT PATIENT
    CASSINOTTI, P
    SCHULTZE, D
    SCHLAGETER, P
    CHEVILI, S
    SIEGL, G
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (09) : 701 - 704
  • [4] DIAGNOSTIC ASSAYS WITH MONOCLONAL-ANTIBODIES FOR THE HUMAN-SERUM PARVOVIRUS-LIKE VIRUS (SPLV)
    COHEN, BJ
    MORTIMER, PP
    PEREIRA, MS
    [J]. JOURNAL OF HYGIENE, 1983, 91 (01) : 113 - &
  • [5] NONSTRUCTURAL PROTEIN OF PARVOVIRUSES-B19 AND MINUTE VIRUS OF MICE CONTROLS TRANSCRIPTION
    DOERIG, C
    HIRT, B
    ANTONIETTI, JP
    BEARD, P
    [J]. JOURNAL OF VIROLOGY, 1990, 64 (01) : 387 - 396
  • [6] PARVOVIRUS B19 SPECIFIC DNA IN BONE-MARROW FROM B19 ARTHROPATHY PATIENTS - EVIDENCE FOR B19 VIRUS PERSISTENCE
    FOTO, F
    SAAG, KG
    SCHAROSCH, LL
    HOWARD, EJ
    NAIDES, SJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (03) : 744 - 748
  • [7] PERSISTENT B19 PARVOVIRUS INFECTION IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) - A TREATABLE CAUSE OF ANEMIA IN AIDS
    FRICKHOFEN, N
    ABKOWITZ, JL
    SAFFORD, M
    BERRY, JM
    ANTUNEZDEMAYOLO, J
    ASTROW, A
    COHEN, R
    HALPERIN, I
    KING, L
    MINTZER, D
    COHEN, B
    YOUNG, NS
    [J]. ANNALS OF INTERNAL MEDICINE, 1990, 113 (12) : 926 - 933
  • [8] PERSISTENT PARVOVIRUS B19 INFECTION
    KERR, JR
    CURRAN, MD
    MOORE, JE
    COYLE, PV
    FERGUSON, WP
    [J]. LANCET, 1995, 345 (8957): : 1118 - 1118
  • [9] CHRONIC BONE-MARROW FAILURE DUE TO PERSISTENT B19-PARVOVIRUS INFECTION
    KURTZMAN, GJ
    OZAWA, K
    COHEN, B
    HANSON, G
    OSEAS, R
    YOUNG, NS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (05) : 287 - 294
  • [10] IMMUNE-RESPONSE TO B19 PARVOVIRUS AND AN ANTIBODY DEFECT IN PERSISTENT VIRAL-INFECTION
    KURTZMAN, GJ
    COHEN, BJ
    FIELD, AM
    OSEAS, R
    BLAESE, RM
    YOUNG, NS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (04) : 1114 - 1123